Canada Pension Plan Investment Board’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $131M | Buy |
209,911
+22,358
| +12% | +$15.2M | 0.07% | 239 |
|
|
2026
Q1 | $145M | Buy |
187,553
+19,186
| +11% | +$14.7M | 0.09% | 200 |
|
|
2025
Q4 | $130M | Buy |
168,367
+9,545
| +6% | +$6.48M | 0.09% | 206 |
|
|
2025
Q3 | $89.3M | Buy |
158,822
+38,019
| +31% | +$21.5M | 0.06% | 242 |
|
|
2025
Q2 | $63.4M | Sell |
120,803
-82,752
| -41% | -$46.2M | 0.05% | 278 |
|
|
2025
Q1 | $129M | Sell |
203,555
-39,918
| -16% | -$27.5M | 0.13% | 158 |
|
|
2024
Q4 | $173M | Buy |
243,473
+96,618
| +66% | +$81.1M | 0.17% | 125 |
|
|
2024
Q3 | $154M | Buy |
146,855
+12,093
| +9% | +$13.5M | 0.15% | 139 |
|
|
2024
Q2 | $142M | Buy |
134,762
+9,472
| +8% | +$9.18M | 0.14% | 149 |
|
|
2024
Q1 | $121M | Sell |
125,290
-1,616
| -1% | -$1.54M | 0.13% | 162 |
|
|
2023
Q4 | $111M | Sell |
126,906
-13,600
| -10% | -$11.2M | 0.14% | 162 |
|
|
2023
Q3 | $116M | Buy |
140,506
+37,000
| +36% | +$29.1M | 0.17% | 141 |
|
|
2023
Q2 | $74.4M | Buy |
103,506
+5,000
| +5% | +$3.86M | 0.11% | 186 |
|
|
2023
Q1 | $80.9M | Buy |
98,506
+34,550
| +54% | +$26.1M | 0.13% | 166 |
|
|
2022
Q4 | $46.1M | Buy |
63,956
+8,800
| +16% | +$6.49M | 0.08% | 219 |
|
|
2022
Q3 | $38M | Buy |
55,156
+32,993
| +149% | +$20.8M | 0.06% | 253 |
|
|
2022
Q2 | $13.1M | Sell |
22,163
-11,006
| -33% | -$7.15M | 0.02% | 394 |
|
|
2022
Q1 | $23.2M | Sell |
33,169
-97,265
| -75% | -$61.5M | 0.03% | 374 |
|
|
2021
Q4 | $82.4M | Sell |
130,434
-11,467
| -8% | -$7.05M | 0.09% | 228 |
|
|
2021
Q3 | $85.9M | Sell |
141,901
-8,857
| -6% | -$5.5M | 0.1% | 214 |
|
|
2021
Q2 | $84.2M | Buy |
150,758
+104,718
| +227% | +$53.1M | 0.1% | 211 |
|
|
2021
Q1 | $21.8M | Buy |
46,040
+39,348
| +588% | +$19.2M | 0.03% | 396 |
|
|
2020
Q4 | $3.23M | Buy |
6,692
+1,301
| +24% | +$702K | ﹤0.01% | 699 |
|
|
2020
Q3 | $3.02M | Sell |
5,391
-12,353
| -70% | -$7.49M | 0.01% | 579 |
|
|
2020
Q2 | $11.1M | Buy |
17,744
+201
| +1% | +$114K | 0.02% | 348 |
|
|
2020
Q1 | $8.57M | Sell |
17,543
-11,896
| -40% | -$4.91M | 0.02% | 397 |
|
|
2019
Q4 | $11.1M | Sell |
29,439
-162,244
| -85% | -$54.6M | 0.02% | 426 |
|
|
2019
Q3 | $53.2M | Sell |
191,683
-35,857
| -16% | -$10.6M | 0.11% | 160 |
|
|
2019
Q2 | $71.2M | Buy |
227,540
+66,191
| +41% | +$22M | 0.14% | 128 |
|
|
2019
Q1 | $66.3M | Buy |
161,349
+14,275
| +10% | +$5.88M | 0.13% | 134 |
|
|
2018
Q4 | $54.9M | Buy |
147,074
+41,449
| +39% | +$15.2M | 0.12% | 135 |
|
|
2018
Q3 | $42.7M | Sell |
105,625
-128,741
| -55% | -$49M | 0.08% | 203 |
|
|
2018
Q2 | $80.9M | Buy |
234,366
+108,691
| +86% | +$34M | 0.16% | 120 |
|
|
2018
Q1 | $43.3M | Buy |
125,675
+27,900
| +29% | +$9.7M | 0.07% | 220 |
|
|
2017
Q4 | $36.8M | Buy |
97,775
+61,600
| +170% | +$24.9M | 0.07% | 242 |
|
|
2017
Q3 | $16.2M | Buy |
36,175
+14,147
| +64% | +$6.73M | 0.03% | 402 |
|
|
2017
Q2 | $10.8M | Sell |
22,028
-19,229
| -47% | -$8.41M | 0.02% | 474 |
|
|
2017
Q1 | $16M | Buy |
41,257
+40,295
| +4,189% | +$14.9M | 0.04% | 342 |
|
|
2016
Q4 | $353K | Buy |
962
+448
| +87% | +$170K | ﹤0.01% | 893 |
|
|
2016
Q3 | $207K | Buy |
514
+479
| +1,369% | +$192K | ﹤0.01% | 958 |
|
|
2016
Q2 | $12K | Sell |
35
-1,880
| -98% | -$724K | ﹤0.01% | 1052 |
|
|
2016
Q1 | $690K | Sell |
1,915
-98
| -5% | -$40.4K | ﹤0.01% | 870 |
|
|
2015
Q4 | $1.09M | Buy |
2,013
+803
| +66% | +$435K | 0.01% | 795 |
|
|
2015
Q3 | $563K | Sell |
1,210
-701
| -37% | -$376K | ﹤0.01% | 930 |
|
|
2015
Q2 | $975K | Sell |
1,911
-12,992
| -87% | -$6.34M | ﹤0.01% | 834 |
|
|
2015
Q1 | $6.73M | Buy |
14,903
+9,622
| +182% | +$4.08M | 0.02% | 540 |
|
|
2014
Q4 | $2.17M | Buy |
5,281
+2,951
| +127% | +$1.16M | 0.01% | 759 |
|
|
2014
Q3 | $840K | Buy |
2,330
+393
| +20% | +$132K | ﹤0.01% | 825 |
|
|
2014
Q2 | $547K | Sell |
1,937
-5,830
| -75% | -$1.73M | ﹤0.01% | 874 |
|
|
2014
Q1 | $2.33M | Sell |
7,767
-5,937
| -43% | -$1.83M | 0.01% | 713 |
|
|
2013
Q4 | $3.77M | Buy |
13,704
+7,190
| +110% | +$2.07M | 0.02% | 641 |
|
|
2013
Q3 | $2.04M | Buy |
6,514
+1,211
| +23% | +$319K | 0.01% | 662 |
|
|
2013
Q2 | $1.19M | Buy |
+5,303
| New | +$1.23M | 0.01% | 629 |
|
Other funds holding REGN
Canada Pension Plan Investment Board's REGN Position: Q2 2026 in Review
Canada Pension Plan Investment Board increased its Regeneron Pharmaceuticals (REGN) stake by 12% in Q2 2026, buying an estimated $15.2M and bringing the position to 209,911 shares worth $131M. The position accounts for 0.07% of the portfolio, ranked #239.
Canada Pension Plan Investment Board first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $173M in Q4 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Canada Pension Plan Investment Board held 209,911 shares of Regeneron Pharmaceuticals worth $131M as of Q2 2026.
- Canada Pension Plan Investment Board bought 22,358 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $15.2M.
- Regeneron Pharmaceuticals made up 0.07% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #239 holding.
- Canada Pension Plan Investment Board first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Canada Pension Plan Investment Board's Regeneron Pharmaceuticals position peaked at $173M in Q4 2024.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.